Cite
MLA Citation
Takuji Komeda et al.. “Post-marketing safety evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir: A drug-use investigation in patients with high risk factors.” Journal of infection and chemotherapy, vol. 22, no. 10, n.d., pp. 677–684. http://access.bl.uk/ark:/81055/vdc_100036195484.0x000023